Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03106766 · ClinicalTrials.gov registry record · Early Phase 1
Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.
A Early Phase 1 study, sponsored by Next Science TM.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT03106766 is a Early Phase 1 study that was terminated before completion, run by Next Science TM. The registered enrollment target is 2 participants.
The verdict
NCT03106766, a Early Phase 1 study, was terminated before completion, sponsored by Next Science TM.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.
Interventions
- DRUG Acne cream 2X
- DRUG Acne cream 1X
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2017-08-14 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03106766
The ClinicalTrials.gov registry entry for NCT03106766 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Next Science TM, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acne cream 2X is the first listed.
NCT03106766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03106766 about?
NCT03106766 is a clinical study titled "Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.". To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind ...
What is the current status of trial NCT03106766?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2017-03-27. Estimated completion is 2017-08-14.
What interventions are being tested in trial NCT03106766?
The interventions under investigation include: Acne cream 2X (DRUG), Acne cream 1X (DRUG).
Who is sponsoring clinical trial NCT03106766?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.